| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |